Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Sierra Oncology, Inc. (SRRA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/22/2022 |
SC 13G
| Versor Investments LP reports a 5.3% stake in SIERRA ONCOLOGY, INC. |
| 02/07/2022 |
SC 13G
| PFM Health Sciences, LP reports a 5.5% stake in Sierra Oncology, Inc. |
| 08/16/2021 |
SC 13G
| Frazier Life Sciences Public Fund, L.P. reports a 9.5% stake in Sierra Oncology, Inc. |
| 04/01/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/19/2020 |
SC 13G
| Rock Springs Capital Management LP reports a 5.3% stake in Sierra Oncology, Inc. |
| 02/10/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/03/2020 |
SC 13G
| CAXTON CORP reports a 9.9% stake in Sierra Oncology, Inc. |
| 01/13/2020 |
SC 13G
| MANGROVE PARTNERS reports a 10% stake in SIERRA ONCOLOGY, INC. |
| 11/25/2019 |
SC 13G
| Vivo Opportunity, LLC reports a 15.1% stake in Sierra Oncology, Inc. |
| 11/25/2019 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Sierra Oncology, Inc. |
| 09/07/2018 |
SC 13G
| Broadfin Capital, LLC reports a 5.5% stake in Sierra Oncology, Inc. |
| 02/13/2018 |
SC 13G
| ORBIMED ADVISORS LLC reports a 6.1% stake in Sierra Oncology, Inc. |
| 11/27/2017 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 7% stake in Sierra Oncology, Inc. |
|
|